References

Adshead S Anaesthesia and nursing consideration of the SA ophthalmic patient. VN Times. 2012; 12:(12)22-3

Understanding neuromuscular blockade. Excel CPD. 2012. http://ecpd-vetnurse.com/2012/05/26/understanding-neuromuscular-blockade-with-course-notes-online-vet-nurse-cpd/ (accessed 19th November, 2012)

Arnot-Smith J, Smith AF Patient safety incidents involving neuromuscular blockade: analysis of the UK National Reporting and Learning Systems data from 2006 to 2008. Journal of the association of anaesthesia of Great Britain and Ireland. 2010; 65:1106-13

Bowcott A Nursing the Canine Bilateral Cataract patient: A Case Study. VN Times. 2011; 11:(9)14-16

Bowman WC Neuromuscular Block. Br J Pharmacol. 2006; 147:(S1)277-86 https://doi.org//10.1038/sj.bjp.0706404/pdf

Syringe Labelling in Critical Care Areas. The Royal College of Anaesthetists. 2004. http://www.rcoa.ac.uk/document-store/syringe-labelling-critical-care-areas (accessed 6th December, 2012)

Clutton E Surgical muscle relaxation and neuromuscular blockade. In Practice. 2007; 29:574-83

Crompton S, Hill P Post operative recovery of the surgical patient. The Veterinary Nurse. 2011; 2:(4)190-8

DeVries M Diabetes Mellitus and anaesthesia: dealing with its potential problems. Veterinary Times. 2011; 41:(28)8-10

Devey JJ, Crowe DT Anaesthesia in the Critically ill or Injured Animal, 2nd ed.. In: Battaglia AM Missouri: Saunders Elsevier; 2007

Dugdale AOxford: Wiley Blackwell; 2010

European Medicine Agency. Bridion – Suugammadex. EMA. 2008. http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000885/human_med_000680.jsp&mid=WC0b01ac058001d124 (accessed 7th December, 2012)

Flaherty D Anaesthetic Drugs, 2nd ed. In: Welsh L Oxford: Wiley Blackwell; 2009

Flaherty D, Auckburally A Muscle Relaxants, 2nd ed.. In: Seymour C, Duke-Noravovski T Gloucester: British Small Animal Veterinary Association; 2007

Hunter JM Antagonising neuromuscular block at the end of surgery. BMJ. 2012; 345 https://doi.org/10.1136/bmj.e6666

Murrell J, Ford-Fennah V Anaesthesia and analgesia, 5th ed. In: Cooper B, Mullineaux E, Turner L Gloucester: British Small Animal Veterinary Association; 2011

Playfor S Neuromuscular Blocking Agents in Critically Ill Children. Paediatric and Perinatal Drug Therapy. 2002; 5:(1)35-46

Neruomuscular Blocking Drugs: Discovery and Development. J R Soc Med. 2002; 95:(7)363-7

Taylor S Intermittent ‘positively practical’ ventilation. Veterinary Nursing Journal. 2011; 26:(10)358-60

Neuromuscular blocking agents — what does a nurse need to know?

02 May 2014
10 mins read
Volume 5 · Issue 4

Abstract

The need for clarification of what is relevant to nurses is required in order for the veterinary nurse to be able to proceed with involvement of patients using neuromuscular blocking agents (NBAs). Available veterinary literature provides information that nurses do not necessarily require, such as the pharmacological compounds of NBAs and ultimately most do not focus on the nursing side of using NBAs, such as ventilation requirements, heating aids and monitoring equipment required. This article highlights what nurses are required to be aware of when participating in NBA use, providing a condensed nursing perspective.

When using neuromuscular blocking agents (NBA) Bowman (2006) states that it is in the skill of the person in charge of the anaesthetic to keep the patient unconscious, so as not to allow the patient to become awake and paralysed, a particularly heavy burden for a nurse that has not had specific training in NBA use. This article will look at the history and relevant areas to nursing care that are required through procedures using NBAs.

Anaesthesia protocols used in veterinary medicine have certain muscle relaxation qualities, however, in order to provide marked muscle relaxation a significantly higher dose of sedative/anaesthetic agent is required, thus causing an increasing risk of morbidity to the patient due to their inherent cardiovascular side effects. The triad of anaesthesia was introduced partly due to the discovery of muscle relaxants. The three points of the triad are hypnosis, analgesia and muscle relaxation (Raghavendra, 2002; Flaherty, 2009). NBAs are required in addition to normal sedative/anaesthetic protocols in order to prevent all skeletal muscle movement during intricate or more complicated surgeries (Bowman, 2006; Murrell and Ford-Fennah, 2011).

Register now to continue reading

Thank you for visiting The Veterinary Nurse and reading some of our peer-reviewed content for veterinary professionals. To continue reading this article, please register today.